Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingCell-targeting antibodies in immunity to EbolaAn EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma.An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies.Co-expression of HER family members in patients with Dukes' C and D colon cancer and their impacts on patient prognosis and survival.Alleviating nonlinear behavior of disulfide isoforms in the reversed-phase liquid chromatography of IgG2.Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cellsDevelopment and validation of a cell-based fluorescent method for measuring antibody affinity.Antibody Engineering for Pursuing a Healthier FutureAcquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation.High-quality production of human α-2,6-sialyltransferase in Pichia pastoris requires control over N-terminal truncations by host-inherent protease activities.Polyester-Based Nanoparticles for the Encapsulation of Monoclonal Antibodies.Trends in Malignant Glioma Monoclonal Antibody Therapy.Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer.Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer
P2860
Q23923997-2EFFBB93-1AE4-4CDF-ACFC-C5B1CFF61D35Q28068972-83796C4C-7693-4BD0-8C84-9ECE27D4E478Q33665884-A1E67A04-5233-493D-81F9-0C8C911122C6Q34276680-0F7B31D0-7BD9-47D0-A05E-CDF43E0AEF57Q35114983-EAD087F3-1DEE-4E07-B87A-5E58836D7B1DQ36161091-2C056378-FFC7-4871-963C-FBF6CCA3A6FDQ37269115-A57A647C-32AF-482F-A18A-0E1E6BA0E61EQ37337898-F95C3130-BBE5-4829-B505-CB7E58ADCB47Q37687763-2B7347BF-CF29-4911-83BE-DD48E0C57AD0Q38724223-2952BF94-0C2E-4490-9617-B8CCD6618E60Q38731632-3D0FACC4-F383-45D0-ACC8-A5AB34AE6953Q38835146-4484BCFA-93C3-407F-A244-BDC714F0191AQ39049314-A16FCA64-8510-47FB-AB1F-02792E46BA05Q40601021-71DF24B0-B361-49D0-BFDC-4E4D178A8015Q41828383-BD142522-EFC6-46EF-9344-D17536F6CDF0Q42585968-4CC99D66-4FEB-44B2-803F-41D1825A43C8Q42608228-C1D66E5E-49EA-44BE-9CFB-5B654388B73FQ47664243-D2EED7AF-612D-447B-B145-ED6991E256A9Q54942652-BA6FB9C2-4B06-4938-A786-4F7A2FE60A13Q54979642-0D2357BB-204D-418B-B66E-DF09B2FDE966Q55004536-AD6FA639-AB95-41DE-86B8-5D2E7255CC19Q58803669-EA429020-71AC-41CF-8ECC-C7231C3DB688
P2860
Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
@en
type
label
Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
@en
prefLabel
Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
@en
P2860
P356
P1476
Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
@en
P2093
Sharadah Essapen
Sumaira Ali
P2860
P356
10.1093/BMB/LDS032
P577
2012-10-31T00:00:00Z